Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew G Annis

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|June 21, 2024
Anti-Claudin-2 Antibody-Drug Conjugates for the Treatment of Colorectal Cancer Liver MetastasisSébastien Tabariès, Alma Robert, Anne Marcil, et al.
Elife|June 28, 2021
Resistance to different anthracycline chemotherapeutics elicits distinct and actionable primary metabolic dependencies in breast cancerShawn McGuirk, Yannick Audet-Delage, Matthew G Annis, et al.
Cell Metabolism|September 15, 2015
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast CancerFanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, et al.
Cell Reports|June 27, 2019
Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver MetastasisBrian E Hsu, Sébastien Tabariès, Radia M Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2024
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancerRegina Cencic, Young K Im, Sai Kiran Naineni, et al.
Redox Biology|January 11, 2024
p66ShcA promotes malignant breast cancer phenotypes by alleviating energetic and oxidative stressKyle Lewis, Rachel La Selva, Elias Maldonado, et al.
Breast Cancer Research : BCR|January 17, 2020
p66ShcA functions as a contextual promoter of breast cancer metastasisKyle Lewis, Alex Kiepas, Jesse Hudson, et al.
Communications Biology|June 3, 2021
Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth patternSébastien Tabariès, Matthew G Annis, Anthoula Lazaris, et al.
Redox Biology|July 25, 2024
Metastatic breast cancer cells are metabolically reprogrammed to maintain redox homeostasis during metastasisMarco Biondini, Camille Lehuédé, Sébastien Tabariès, et al.
Neuro-Oncology|January 12, 2021
Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastasesMatthew Dankner, Maxime Caron, Tariq Al-Saadi, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|June 21, 2024
Anti-Claudin-2 Antibody-Drug Conjugates for the Treatment of Colorectal Cancer Liver MetastasisSébastien Tabariès, Alma Robert, Anne Marcil, et al.
Elife|June 28, 2021
Resistance to different anthracycline chemotherapeutics elicits distinct and actionable primary metabolic dependencies in breast cancerShawn McGuirk, Yannick Audet-Delage, Matthew G Annis, et al.
Cell Metabolism|September 15, 2015
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast CancerFanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, et al.
Cell Reports|June 27, 2019
Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver MetastasisBrian E Hsu, Sébastien Tabariès, Radia M Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2024
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancerRegina Cencic, Young K Im, Sai Kiran Naineni, et al.
Redox Biology|January 11, 2024
p66ShcA promotes malignant breast cancer phenotypes by alleviating energetic and oxidative stressKyle Lewis, Rachel La Selva, Elias Maldonado, et al.
Breast Cancer Research : BCR|January 17, 2020
p66ShcA functions as a contextual promoter of breast cancer metastasisKyle Lewis, Alex Kiepas, Jesse Hudson, et al.
Communications Biology|June 3, 2021
Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth patternSébastien Tabariès, Matthew G Annis, Anthoula Lazaris, et al.
Redox Biology|July 25, 2024
Metastatic breast cancer cells are metabolically reprogrammed to maintain redox homeostasis during metastasisMarco Biondini, Camille Lehuédé, Sébastien Tabariès, et al.
Neuro-Oncology|January 12, 2021
Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastasesMatthew Dankner, Maxime Caron, Tariq Al-Saadi, et al.
Pageof 5